PHOENIX, Dec. 20, 2018 /PRNewswire/ -- NeoLight, an empathy-driven medical device company that designs, engineers, and manufactures technologies to treat infants with life-threatening medical conditions, announces that its co-founder and Chief Executive Officer, Vivek Kopparthi, will present at Biotech Showcase 2019, as part of the Digital Medicine and Medtech Showcase, to be held January 6-9, 2019, at the Hilton San Francisco Union Square.
Details of NeoLight's presentation are as follows:
Event: | Digital Medicine and Medtech Showcase at Biotech Showcase | |
Date: | Tuesday, January 8, 2019 | |
Time: | 9:15 a.m. (Pacific Time) | |
Location: | Hilton San Francisco Union Square |
Mr. Kopparthi will provide an update on business development and an ongoing efficacy study of company's lead product, Skylife™, a neonatal phototherapy device recently cleared by the U.S. Food and Drug Administration (FDA) to treat hyperbilirubinemia, commonly known as Jaundice.
About NeoLight
NeoLight is a next-generation medical device company that designs and delivers technologies to treat infants with life threatening medical conditions. The company's mission is to reinvent newborn care through empathy-driven innovation. Their approach always starts with what is best for the baby. Backed by Dignity Health and Honor Health, this Phoenix based startup aims to disrupt the newborn care market - a laggard in healthcare innovation.
Contacts:
Tiberend Strategic Advisors, Inc.
Joshua Drumm, Ph.D. (Investors)
(212) 375-2664
jdrumm@tiberend.com
Dave Schemelia (Media)
(212) 375-2686
dschemelia@tiberend.com
SOURCE NeoLight
